
    
      To evaluate the safety and efficacy of the Paclitaxel Eluting Hemodialysis Shunt Balloon
      Dilatation Catheter (APERTO) compared with the Balloon Dilatation catheter (OHICHO II) for
      the treatment of Arteriovenous Fistulae Stenosis in patients undergoing hemodialysis.

      This is a prospective, multi-center, randomized controlled, open-label, superiority study. A
      total of 160 subjects will be enrolled from 10 sites in China. All subjects enrolled will be
      randomly assigned to the test group (APERTO group, n=80) and the control group (OHICHO II
      group, n=80) with randomized allocation ratio of 1:1. Subjects in the test group and the
      control group will be treated with APERTO OTW or OHICHO II respectively.
    
  